Drug-resistant tuberculosis
Do you want to receive a message when there is new research on Drug-resistant tuberculosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you receive a notification as soon as new research on Drug-resistant tuberculosis becomes available. View what Premium costs.
Publications and studies (1454)
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002) (2018-06-28) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Tuberculosis in China (2018-04-05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Multi-Drug Resistant Tuberculosis in Korea (2018-04-05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali (2018-04-05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis (2018-01-30) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. PK of Levofloxacin in MDR-TB Patients (2018-01-25) ♡
- A significant therapeutic effect of immunoglobulins administered alone, or in combination with conventional chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains. (2017/12/29) ♡
- Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa. (2017/12/28) ♡
- A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. (2017/12/28) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis. (2017/12/28) ♡
- Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru. (2017/12/27) ♡
- Clinical challenges in the era of multiple and extensively drug-resistant tuberculosis. (2017/12/26) ♡
- Urogenital tuberculosis, the cause of ineffective antibacterial therapy for urinary tract infections. (2017/12/22) ♡
- Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis. (2017/12/21) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter? (2017/12/21) ♡
- Patients with MDR-TB on domiciliary care in programmatic settings in Myanmar: Effect of a support package on preventing early deaths. (2017/12/20) ♡
- Deletion of TGF-β1 Increases Bacterial Clearance by Cytotoxic T Cells in a Tuberculosis Granuloma Model. (2017/12/20) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Clinical and Immunological Effects of rhIL-2 Therapy in Eastern Chinese Patients with Multidrug-resistant Tuberculosis. (2017/12/19) ♡
- Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey. (2017/12/15) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Molecular Drug-Susceptibility Test for Tuberculosis. (2017/12/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity. (2017/12/11) ♡
- Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis. (2017/12/11) ♡
- Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis. (2017/12/06) ♡
- Genome-wide transcriptional profiling identifies potential signatures in discriminating active tuberculosis from latent infection. (2017/12/04) ♡
- Trace elements in blood samples of smoker and nonsmoker active pulmonary tuberculosis patients from Jamshoro, Pakistan. (2017/12/01) ♡
- Applying optimization algorithms to tuberculosis antibiotic treatment regimens. (2017/12/01) ♡
- World Health Organization recommendations for multidrug-resistant tuberculosis: should different standards be applied? (2017/12/01) ♡
- Renal function of MDR-TB patients treated with kanamycin regimens or concomitantly with antiretroviral agents. (2017/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Fluoroquinolones and dairy intake: dogma or evidence? Considerations on the short-course regimen for children. (2017/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pulmonary resection in the treatment of multidrug-resistant tuberculosis: A case series. (2017/12/01) ♡
- High Resolution Melting Curve Analysis for Rapid Detection of Streptomycin and Ethambutol Resistance in Mycobacterium tuberculosis. (2017/12/01) ♡
- Examining the role of protein structural dynamics in drug resistance in Mycobacterium tuberculosis. (2017/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mycobacteria-derived biomarkers for tuberculosis diagnosis. (2017/12/01) ♡
- Molecular Characterization of Prothionamide-Resistant Mycobacterium tuberculosis Isolates in Southern China. (2017/11/30) ♡
- S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope. (2017/11/30) ♡
- Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions. (2017/11/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences. (2017/11/27) ♡
- The Alternative Sigma Factors SigE and SigB Are Involved in Tolerance and Persistence to Antitubercular Drugs. (2017/11/22) ♡
- Factors associated with tuberculosis treatment outcomes among tuberculosis patients attending tuberculosis treatment centres in 2016-2017 in Mogadishu, Somalia. (2017/11/02) ♡
- Tuberculosis drug resistance in Canada: 2006-2016. (2017/11/02) ♡
- Evaluation of the impact that the changes in tuberculosis treatment implemented in Brazil in 2009 have had on disease control in the country. (2017/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tuberculosis treatment. (2017/11/01) ♡
- Extraspinal osteoarticular multidrug-resistant tuberculosis in children: A case series. (2017/10/31) ♡
- Genotyping and molecular detection of multidrug-resistant Mycobacterium tuberculosis among tuberculosis lymphadenitis cases in Addis Ababa, Ethiopia. (2017/10/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes. (2017/10/03) ♡
- Predicting treatment failure, death and drug resistance using a computed risk score among newly diagnosed TB patients in Tamaulipas, Mexico. (2017/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of Vitamins B, C, and D in the fight against tuberculosis. (2017/10/01) ♡
- Vitamin D, cell death pathways, and tuberculosis. (2017/10/01) ♡
- Association of Risk Factors and Drug Resistance Pattern in Tuberculosis Patients in North India. (2017/10/01) ♡
- Cytochrome b and Molecular Typing of Leishmania spp. in a Passive Sampling of Suspected Patients with Cutaneous Leishmaniasis in Sistan and Baluchestan Province, Eastern Iran. (2017/10/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.